Previously Known As : Sbi Pharma Fund
Sbi Healthcare Opportunities Fund Datagrid
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 11-09-2026
NAV ₹523.06(R) -0.28% ₹605.91(D) -0.28%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 20.2% 22.97% 17.43% 24.65% 13.7%
Direct 21.41% 24.25% 18.67% 25.98% 14.95%
Nifty Pharma TRI 20.11% 20.92% 13.86% 19.36% 9.36%
SIP (XIRR) Regular 33.53% 20.33% 22.42% 22.11% 19.59%
Direct 34.84% 21.55% 23.69% 23.41% 20.83%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.2 0.63 1.09 2.39% 0.23
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
14.65% -15.67% -12.33% 0.82 10.68%
Fund AUM As on: 30/12/2025 4058 Cr

NAV Date: 11-09-2026

Scheme Name NAV Rupee Change Percent Change
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 329.5
-0.9300
-0.2800%
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 420.97
-1.1800
-0.2800%
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 523.06
-1.4800
-0.2800%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 605.91
-1.7000
-0.2800%

Review Date: 11-09-2026

Beginning of Analysis

The 5 star rating shows an excellent past performance of the SBI Healthcare Opportunities Fund in Pharma Fund. The SBI Healthcare Opportunities Fund has a Jensen Alpha of 2.39% which is higher than the category average of 1.66%. Here the SBI Healthcare Opportunities Fund has shown good performance in terms of risk adjusted returns. The SBI Healthcare Opportunities Fund has a Sharpe Ratio of 1.2 which is higher than the category average of 1.04. Here the SBI Healthcare Opportunities Fund has shown very good performance in terms of risk adjusted returns.
The past performance of the {fund_name_eng} may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds.
Pharma Mutual Funds

SBI Healthcare Opportunities Fund Return Analysis

The SBI Healthcare Opportunities Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Pharma Fund peers and the Nifty Pharma TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Pharma Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of -0.34%, 11.62 and 22.59 in last one, three and six months respectively. In the same period the category average return was -0.16%, 10.31% and 19.62% respectively.
  • SBI Healthcare Opportunities Fund has given a return of 21.41% in last one year. In the same period the Nifty Pharma TRI return was 20.11%. The fund has given 1.3% more return than the benchmark return.
  • The fund has given a return of 24.25% in last three years and rank 1st out of ten funds in the category. In the same period the Nifty Pharma TRI return was 20.92%. The fund has given 3.33% more return than the benchmark return.
  • SBI Healthcare Opportunities Fund has given a return of 18.67% in last five years and category average returns is 15.51% in same period. The fund ranked 1.0st out of eight funds in the category. In the same period the Nifty Pharma TRI return was 13.86%. The fund has given 4.81% more return than the benchmark return.
  • The fund has given a return of 14.95% in last ten years and ranked 2.0nd out of four funds in the category. In the same period the Nifty Pharma TRI return was 9.36%. The fund has given 5.59% more return than the benchmark return.
  • The fund has given a SIP return of 34.84% in last one year whereas category average SIP return is 29.55%. The fund one year return rank in the category is 6th in 16 funds
  • The fund has SIP return of 21.55% in last three years and ranks 1st in 10 funds. The fund has given the highest SIP return in the category in last three years.
  • The fund has SIP return of 23.69% in last five years whereas category average SIP return is 20.29%.

SBI Healthcare Opportunities Fund Risk Analysis

  • The fund has a standard deviation of 14.65 and semi deviation of 10.68. The category average standard deviation is 15.94 and semi deviation is 11.38.
  • The fund has a Value at Risk (VaR) of -15.67 and a maximum drawdown of -12.33. The category average VaR is -18.94 and the maximum drawdown is -14.76. The fund has a beta of 0.77 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Pharma Fund Category
  • Good Performance in Pharma Fund Category
  • Poor Performance in Pharma Fund Category
  • Very Poor Performance in Pharma Fund Category

  • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -0.43 -0.81
    -0.26
    -3.52 | 2.61 9 | 17 Good
    3M Return % 11.35 9.43
    9.95
    3.71 | 14.57 6 | 17 Good
    6M Return % 21.99 14.04
    18.81
    10.31 | 25.91 6 | 17 Good
    1Y Return % 20.20 20.11
    16.37
    5.48 | 26.06 5 | 16 Good
    3Y Return % 22.97 20.92
    20.38
    17.52 | 22.97 1 | 10 Very Good
    5Y Return % 17.43 13.86
    14.14
    12.63 | 17.43 1 | 8 Very Good
    7Y Return % 24.65 19.36
    22.64
    19.61 | 24.65 1 | 8 Very Good
    10Y Return % 13.70 9.36
    13.82
    13.08 | 14.74 3 | 4 Average
    15Y Return % 17.86 13.25
    16.79
    15.58 | 17.86 1 | 3 Very Good
    1Y SIP Return % 33.53
    27.85
    10.89 | 41.93 5 | 16 Good
    3Y SIP Return % 20.33
    15.94
    11.98 | 20.33 1 | 10 Very Good
    5Y SIP Return % 22.42
    18.88
    16.31 | 22.42 1 | 8 Very Good
    7Y SIP Return % 22.11
    19.39
    17.40 | 22.11 1 | 8 Very Good
    10Y SIP Return % 19.59
    18.18
    16.94 | 19.59 1 | 4 Very Good
    15Y SIP Return % 17.04
    16.37
    15.68 | 17.04 1 | 3 Very Good
    Standard Deviation 14.65
    15.95
    14.65 | 16.87 1 | 8 Very Good
    Semi Deviation 10.68
    11.39
    10.68 | 12.13 1 | 8 Very Good
    Max Drawdown % -12.33
    -14.76
    -16.36 | -12.33 1 | 8 Very Good
    VaR 1 Y % -15.67
    -18.95
    -23.32 | -15.67 1 | 8 Very Good
    Average Drawdown % 5.39
    5.47
    3.66 | 6.79 5 | 8 Average
    Sharpe Ratio 1.20
    1.04
    0.87 | 1.20 1 | 8 Very Good
    Sterling Ratio 1.09
    0.94
    0.81 | 1.09 1 | 8 Very Good
    Sortino Ratio 0.63
    0.54
    0.44 | 0.63 1 | 8 Very Good
    Jensen Alpha % 2.39
    1.66
    -0.46 | 3.84 4 | 8 Good
    Treynor Ratio 0.23
    0.20
    0.16 | 0.23 1 | 8 Very Good
    Modigliani Square Measure % 19.86
    17.20
    14.35 | 19.86 1 | 8 Very Good
    Alpha % -0.61
    0.06
    -1.73 | 3.02 4 | 8 Good
    Return data last Updated On : Sept. 11, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -0.34 -0.81 -0.16 -3.47 | 2.74 9 | 17 Good
    3M Return % 11.62 9.43 10.31 3.91 | 15.06 6 | 17 Good
    6M Return % 22.59 14.04 19.62 10.78 | 26.98 6 | 17 Good
    1Y Return % 21.41 20.11 17.96 6.34 | 28.09 6 | 16 Good
    3Y Return % 24.25 20.92 21.86 18.57 | 24.25 1 | 10 Very Good
    5Y Return % 18.67 13.86 15.51 13.65 | 18.67 1 | 8 Very Good
    7Y Return % 25.98 19.36 24.15 21.43 | 25.98 1 | 8 Very Good
    10Y Return % 14.95 9.36 15.11 14.86 | 15.76 2 | 4 Good
    1Y SIP Return % 34.84 29.55 11.75 | 44.14 6 | 16 Good
    3Y SIP Return % 21.55 17.36 13.33 | 21.55 1 | 10 Very Good
    5Y SIP Return % 23.69 20.29 17.48 | 23.69 1 | 8 Very Good
    7Y SIP Return % 23.41 20.84 18.82 | 23.41 1 | 8 Very Good
    10Y SIP Return % 20.83 19.48 18.71 | 20.83 1 | 4 Very Good
    Standard Deviation 14.65 15.95 14.65 | 16.87 1 | 8 Very Good
    Semi Deviation 10.68 11.39 10.68 | 12.13 1 | 8 Very Good
    Max Drawdown % -12.33 -14.76 -16.36 | -12.33 1 | 8 Very Good
    VaR 1 Y % -15.67 -18.95 -23.32 | -15.67 1 | 8 Very Good
    Average Drawdown % 5.39 5.47 3.66 | 6.79 5 | 8 Average
    Sharpe Ratio 1.20 1.04 0.87 | 1.20 1 | 8 Very Good
    Sterling Ratio 1.09 0.94 0.81 | 1.09 1 | 8 Very Good
    Sortino Ratio 0.63 0.54 0.44 | 0.63 1 | 8 Very Good
    Jensen Alpha % 2.39 1.66 -0.46 | 3.84 4 | 8 Good
    Treynor Ratio 0.23 0.20 0.16 | 0.23 1 | 8 Very Good
    Modigliani Square Measure % 19.86 17.20 14.35 | 19.86 1 | 8 Very Good
    Alpha % -0.61 0.06 -1.73 | 3.02 4 | 8 Good
    Return data last Updated On : Sept. 11, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Sbi Healthcare Opportunities Fund NAV Regular Growth Sbi Healthcare Opportunities Fund NAV Direct Growth
    11-09-2026 523.0597 605.9053
    10-09-2026 524.5428 607.6073
    09-09-2026 525.141 608.2842
    08-09-2026 525.7802 609.0087
    07-09-2026 521.513 604.0502
    04-09-2026 519.2154 601.3416
    03-09-2026 523.0543 605.7718
    02-09-2026 521.6149 604.0889
    01-09-2026 522.2455 604.8033
    31-08-2026 527.3415 610.6889
    28-08-2026 523.6775 606.3981
    27-08-2026 523.2744 605.9154
    26-08-2026 519.9283 602.0252
    25-08-2026 519.0265 600.9648
    24-08-2026 514.1663 595.3215
    21-08-2026 515.7019 597.0514
    20-08-2026 517.8078 599.4733
    18-08-2026 521.1804 603.3454
    17-08-2026 516.94 598.4205
    14-08-2026 520.3617 602.3331
    13-08-2026 519.6331 601.4736
    12-08-2026 520.9162 602.9426
    11-08-2026 525.2989 607.9991

    Fund Launch Date: 01/Jan/1993
    Fund Category: Pharma Fund
    Investment Objective: To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
    Fund Description: An open-ended Equity Scheme investing in healthcare sector
    Fund Benchmark: S&P BSE HEALTHCARE Index
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.